Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Prophylaxis effect of...

    Prophylaxis effect of hydroxychloroquine in COVID-19: Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-28T12:52:39+05:30  |  Updated On 28 March 2020 12:52 PM IST
    Prophylaxis effect of hydroxychloroquine in COVID-19:  Rising Pharmaceuticals, Laurus Labs collaborate to support University of Minnesota research

    The trial is being led by internationally recognized infectious disease expert David Boulware, MD, MPH and his research team among 1,500 healthcare workers or household contacts exposed to COVID-19. In non-human studies, researchers have identified two medicines, chloroquine and hydroxychloroquine, as having activity against SARS-coronaviruses.

    Hyderabad: Rising Pharma Holdings Inc., the global pharmaceutical company operating as Rising Pharmaceuticals has announced its collaborative agreement with the Division of Infectious Disease and International Medicine at the University of Minnesota, Department of Infectious Disease on a clinical trial exploring hydroxychloroquine as a preventive treatment for coronavirus disease 2019 (COVID-19). Hydroxychloroquine is a medication used for the prevention and treatment of certain types of malaria, as well as rheumatoid arthritis, lupus, and porphyria cutanea tarda.

    The trial is being led by internationally recognized infectious disease expert David Boulware, MD, MPH and his research team among 1,500 healthcare workers or household contacts exposed to COVID-19. In non-human studies, researchers have identified two medicines, chloroquine and hydroxychloroquine, as having activity against SARS-coronaviruses.

    "New drugs could save the lives of severely ill patients, and given prophylactically, can also protect health care workers and others at high risk of infection," said Dr. Boulware in commenting on the collaboration. "We are grateful for the fast-track support of industry with this important study and believe our efforts will provide important answers about dealing with this virus."

    Rising Pharmaceuticals -- and its partner Laurus Labs Limited in Hyderabad, India -- manufacture Hydroxychloroquine Sulphate, USP Tablets under an FDA approved drug application. Rising Pharmaceuticals is the exclusive distributor of the product in the United States.

    Vimal Kavuru, CEO of Rising Pharmaceuticals said, "We started talking to the University of Minnesota just over a week ago and have fast-tracked our efforts to support this critically needed study. We are actively supporting research in this area to help build better clinical guidelines."

    Dr. Satyanarayana Chava, CEO of Laurus Labs Limited added, "We are proud to assist this reputable institution and assist in the ongoing search for effective therapeutics against this global pandemic. We hope this research will underscore the clinical benefit of this drug in protecting our brave healthcare workers."

    Read also: Laurus Labs gets 3 USFDA observations for Visakhapatnam facility


    rising-pharmahydroxychloroquinecoronaviruscovid-19laurus-labsuniversity-of-minnesota

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok